Last reviewed · How we verify

nomegestrol acetate and estradiol

Organon and Co · Phase 1 active Small molecule

nomegestrol acetate and estradiol is a Small molecule drug developed by Organon and Co. It is currently in Phase 1 development. Also known as: NOMAC-E2; Org 10486-0 + Org 2317.

At a glance

Generic namenomegestrol acetate and estradiol
Also known asNOMAC-E2; Org 10486-0 + Org 2317
SponsorOrganon and Co
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about nomegestrol acetate and estradiol

What is nomegestrol acetate and estradiol?

nomegestrol acetate and estradiol is a Small molecule drug developed by Organon and Co.

Who makes nomegestrol acetate and estradiol?

nomegestrol acetate and estradiol is developed by Organon and Co (see full Organon and Co pipeline at /company/organon-and-co).

Is nomegestrol acetate and estradiol also known as anything else?

nomegestrol acetate and estradiol is also known as NOMAC-E2; Org 10486-0 + Org 2317.

What development phase is nomegestrol acetate and estradiol in?

nomegestrol acetate and estradiol is in Phase 1.

Related